Health, C., 2023. CADTH Reimbursement Recommendation - Setmelanotide (Imcivree) - Indication: For weight management in adult and pediatric patients 6 years of, Canadian Agency for Drugs and Technologies in Health.
Canada
Retrieved from https://policycommons.net/artifacts/8189854/cadth-reimbursement-recommendation-setmelanotide-imcivree-indication/9100263/fragments/4336124/ on 26 Jul 2024. CID: 20.500.12592/4tgbx8.
Download citation (RIS)